News & Updates
Filter by Specialty:

VIDEO: Apalutamide’s tolerability in prostate cancer patients
19 May 2025
byDr. Darren Poon, Specialist in Clinical Oncology , Hong Kong Sanatorium & Hospital, Chinese University of Hong Kong , Hong Kong
Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, discusses apalutamide’s tolerability in prostate cancer patients.
VIDEO: Apalutamide’s tolerability in prostate cancer patients
19 May 2025
Tapered vancomycin dosing reduces CDI recurrence
18 May 2025
byJairia Dela Cruz
Tapering the dose of vancomycin over 2 weeks following initial 14-day therapy appears to work better than the 14-day fixed dosing at reducing the recurrence of Clostridioides difficile infection (CDI), as shown in the TAPER-V trial.